Aeglea BioTherapeutics Announces Presentations at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2022
AUSTIN, Texas, Aug. 29, 2022 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new ...
United States Emory University School Of Medicine Rossana Sanchez Russo Aeglea Biotherapeutics Georgiaabout Aeglea Biotherapeutics Danielle Starin
Source: businessinsider.com